Evidence map›Paper›PMID 33558602›Full record

ArticleScientific reports2021

A multipurpose machine learning approach to predict COVID-19 negative prognosis in São Paulo, Brazil.

Fernando Timoteo Fernandes, Tiago Almeida de Oliveira, Cristiane Esteves Teixeira, Andre Filipe de Moraes Batista, Gabriel Dalla Costa, Alexandre Dias Porto Chiavegatto Filho

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Prediction models for COVID-19 disease outcomes.Emerging microbes & infections · 2024
    Article
  3. Article
  4. Review
  5. Artificial intelligence in triage of COVID-19 patients.Frontiers in artificial intelligence · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The value of machine learning for prognosis prediction of diphenhydramine exposure: National analysis of 50,000 patients in the United States.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fernando Timoteo FernandesSchool of Public Health, University of São Paulo, São Paulo, SP, Brazil. fernando.fernandes@fundacentro.gov.br.
Tiago Almeida de OliveiraSchool of Public Health, University of São Paulo, São Paulo, SP, Brazil.
Cristiane Esteves TeixeiraSchool of Public Health, University of São Paulo, São Paulo, SP, Brazil.
Andre Filipe de Moraes BatistaSchool of Public Health, University of São Paulo, São Paulo, SP, Brazil.
Gabriel Dalla CostaBP-A Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil.
Alexandre Dias Porto Chiavegatto FilhoSchool of Public Health, University of São Paulo, São Paulo, SP, Brazil.
Universidade de São Paulo · BRBeneficência Portuguesa de São Paulo · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 402626/2020-6Fundação de Apoio à Pesquisa do Estado da Paraíba 206/2020
6 · The paper itself

Abstract

The new coronavirus disease (COVID-19) is a challenge for clinical decision-making and the effective allocation of healthcare resources. An accurate prognostic assessment is necessary to improve survival of patients, especially in developing countries. This study proposes to predict the risk of developing critical conditions in COVID-19 patients by training multipurpose algorithms. We followed a total of 1040 patients with a positive RT-PCR diagnosis for COVID-19 from a large hospital from São Paulo, Brazil, from March to June 2020, of which 288 (28%) presented a severe prognosis, i.e. Intensive Care Unit (ICU) admission, use of mechanical ventilation or death. We used routinely-collected laboratory, clinical and demographic data to train five machine learning algorithms (artificial neural networks, extra trees, random forests, catboost, and extreme gradient boosting). We used a random sample of 70% of patients to train the algorithms and 30% were left for performance assessment, simulating new unseen data. In order to assess if the algorithms could capture general severe prognostic patterns, each model was trained by combining two out of three outcomes to predict the other. All algorithms presented very high predictive performance (average AUROC of 0.92, sensitivity of 0.92, and specificity of 0.82). The three most important variables for the multipurpose algorithms were ratio of lymphocyte per C-reactive protein, C-reactive protein and Braden Scale. The results highlight the possibility that machine learning algorithms are able to predict unspecific negative COVID-19 outcomes from routinely-collected data.

Indexed as

Machine LearningAdultAgedAged, 80 and overAlgorithmsBrazilCohort StudiesComputational BiologyCOVID-19C-Reactive ProteinFemaleHumansIntensive Care UnitsLength of StayLymphocyte CountMaleC-Reactive Protein

Identifiers

PMID33558602
PMCPMC7870665
OpenAlexW3126570147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.